13F Insight
DOSSIER · 13F Holders · Q2 2026
AVLN

AVALYN PHARMACEUTICALS INC

2 institutions still hold AVALYN PHARMACEUTICALS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 05348Y105·2 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$31M
visible holders
Holders
2
filers reporting
Concentration
99.46%
Andera Partners #1
top holder share
AI Holders Summary · Q2 2026

2 institutions reported AVLN in Q2 2026. Andera Partners leads at 99.5% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Andera Partners
CIK 0001757283
$31M930K14.82%Q2 202602
Police & Firemen's Retirement System of New Jersey
CIK 0002040686
$166K5K0.00%Q2 2026
Insiders at AVALYN PHARMACEUTICALS INC
Fmr Llc →Carroll Jill →Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. →Lavelle Erin →Carlson Douglas R →Golden Adam H. →Baranowski Lyn →Lazarus Howard →